CLINICAL_TRIALS
trial_result
· 2008-12-18
Clinical Trial Update: Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms [Phase 4]
Summary
Phase 4 trial evaluating memantine as adjunctive therapy for negative symptoms in schizophrenia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED